Company / Tangible Book Value per Share
Edwards Lifesciences Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$14.76
FY2025
5-year range
$7.48 / $14.76
FY2021-FY2025
Trend
+7.9%
vs FY2024
Sector context
#37 of 158
Health Care
What the data says
Edwards Lifesciences's tangible book value per share of $14.76 is higher than 77% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has increased for 5 consecutive years, from $5.45 in FY2020 to $14.76 in FY2025.
Based on SEC 10-K filings.
14.76 in FY2025 with a 5-year CAGR of +22.1%. Top quartile in the Health Care sector.
Improved from $9.02 to $14.76 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +24.6%
- 5-Year CAGR
- +22.1%
- 10-Year CAGR
- -
Sector benchmark
-20.1% below sector average
Key checks
Key Insights
- Edwards Lifesciences's tangible book value per share has grown for 5 consecutive years.
- In FY2025, tangible book value per share increased 7.9% year-over-year.
- Ranks #37 out of 158 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.76 | +7.9% |
| FY2024 | $13.68 | +51.7% |
| FY2023 | $9.02 | +18.2% |
| FY2022 | $7.63 | +2.0% |
| FY2021 | $7.48 | +37.3% |
| FY2020 | $5.45 | -61.8% |
| FY2019 | $14.25 | +46.0% |
| FY2018 | $9.77 | +12.9% |
| FY2017 | $8.65 | -8.2% |
| FY2016 | $9.42 | -45.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026